260 related articles for article (PubMed ID: 11479199)
1. Expression profiling reveals hepsin overexpression in prostate cancer.
Magee JA; Araki T; Patil S; Ehrig T; True L; Humphrey PA; Catalona WJ; Watson MA; Milbrandt J
Cancer Res; 2001 Aug; 61(15):5692-6. PubMed ID: 11479199
[TBL] [Abstract][Full Text] [Related]
2. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
Chen Z; Fan Z; McNeal JE; Nolley R; Caldwell MC; Mahadevappa M; Zhang Z; Warrington JA; Stamey TA
J Urol; 2003 Apr; 169(4):1316-9. PubMed ID: 12629351
[TBL] [Abstract][Full Text] [Related]
3. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
Luo J; Duggan DJ; Chen Y; Sauvageot J; Ewing CM; Bittner ML; Trent JM; Isaacs WB
Cancer Res; 2001 Jun; 61(12):4683-8. PubMed ID: 11406537
[TBL] [Abstract][Full Text] [Related]
4. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer.
Stephan C; Yousef GM; Scorilas A; Jung K; Jung M; Kristiansen G; Hauptmann S; Kishi T; Nakamura T; Loening SA; Diamandis EP
J Urol; 2004 Jan; 171(1):187-91. PubMed ID: 14665873
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.
Halvorsen OJ; Oyan AM; Bø TH; Olsen S; Rostad K; Haukaas SA; Bakke AM; Marzolf B; Dimitrov K; Stordrange L; Lin B; Jonassen I; Hood L; Akslen LA; Kalland KH
Int J Oncol; 2005 Feb; 26(2):329-36. PubMed ID: 15645116
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
[TBL] [Abstract][Full Text] [Related]
7. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
Xuan JA; Schneider D; Toy P; Lin R; Newton A; Zhu Y; Finster S; Vogel D; Mintzer B; Dinter H; Light D; Parry R; Polokoff M; Whitlow M; Wu Q; Parry G
Cancer Res; 2006 Apr; 66(7):3611-9. PubMed ID: 16585186
[TBL] [Abstract][Full Text] [Related]
8. HEPSIN inhibits cell growth/invasion in prostate cancer cells.
Srikantan V; Valladares M; Rhim JS; Moul JW; Srivastava S
Cancer Res; 2002 Dec; 62(23):6812-6. PubMed ID: 12460890
[TBL] [Abstract][Full Text] [Related]
9. Delineation of prognostic biomarkers in prostate cancer.
Dhanasekaran SM; Barrette TR; Ghosh D; Shah R; Varambally S; Kurachi K; Pienta KJ; Rubin MA; Chinnaiyan AM
Nature; 2001 Aug; 412(6849):822-6. PubMed ID: 11518967
[TBL] [Abstract][Full Text] [Related]
10. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.
Welsh JB; Sapinoso LM; Su AI; Kern SG; Wang-Rodriguez J; Moskaluk CA; Frierson HF; Hampton GM
Cancer Res; 2001 Aug; 61(16):5974-8. PubMed ID: 11507037
[TBL] [Abstract][Full Text] [Related]
11. Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.
Li W; Wang BE; Moran P; Lipari T; Ganesan R; Corpuz R; Ludlam MJ; Gogineni A; Koeppen H; Bunting S; Gao WQ; Kirchhofer D
Cancer Res; 2009 Nov; 69(21):8395-402. PubMed ID: 19843851
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia.
Stamey TA; Warrington JA; Caldwell MC; Chen Z; Fan Z; Mahadevappa M; McNeal JE; Nolley R; Zhang Z
J Urol; 2001 Dec; 166(6):2171-7. PubMed ID: 11696729
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U
Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression profiling in prostate cancer.
Porkka KP; Pfeiffer MJ; Waltering KK; Vessella RL; Tammela TL; Visakorpi T
Cancer Res; 2007 Jul; 67(13):6130-5. PubMed ID: 17616669
[TBL] [Abstract][Full Text] [Related]
15. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma.
Lucas JM; True L; Hawley S; Matsumura M; Morrissey C; Vessella R; Nelson PS
J Pathol; 2008 Jun; 215(2):118-25. PubMed ID: 18338334
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.
Ding Y; Xu L; Chen S; Jovanovic BD; Helenowski IB; Kelly DL; Catalona WJ; Yang XJ; Pins M; Ananthanarayanan V; Bergan RC
Prostate Cancer Prostatic Dis; 2006; 9(4):379-91. PubMed ID: 16786039
[TBL] [Abstract][Full Text] [Related]
17. [Gene expression profiling in prostatic cancer].
Ernst T; Hergenhahn M; Kenzelmann M; Cohen CD; Ikinger U; Kretzler M; Hollstein M; Gröne HJ
Verh Dtsch Ges Pathol; 2002; 86():165-75. PubMed ID: 12647366
[TBL] [Abstract][Full Text] [Related]
18. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
19. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
[TBL] [Abstract][Full Text] [Related]
20. Hepsin immunohistochemical expression in prostate cancer in relation to Gleason's grade and serum prostate specific antigen.
Goel MM; Agrawal D; Natu SM; Goel A
Indian J Pathol Microbiol; 2011; 54(3):476-81. PubMed ID: 21934206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
